Target intelligence / Profile preview

Beta-lactamase enzyme (bacterial) (β-lactamase)

Target
β-lactamase
Molecular classification
Enzyme, Hydrolase (EC 3.5.2.6), Serine beta-lactamase (classes A, C, D), Metallo-beta-lactamase (class B), Resistance factor
01

Overview

Beta-lactamase enzymes are bacterial hydrolases that confer resistance to β-lactam antibiotics by hydrolyzing the β-lactam ring, the core structure essential for antibiotic activity[1][2]. Classified into four major molecular classes (A-D), these enzymes can be serine-based or require metal ions (zinc) at their active sites, and their occurrence is a principal mechanism of clinical antibiotic resistance in both Gram-positive and Gram-negative bacteria[3][5]. Beta-lactamases are widespread among pathogenic bacteria, are often transmissible via plasmids, and their presence correlates closely with reduced efficacy of key antibiotic classes[1][5][8]. Several β-lactamase inhibitors have been developed and are clinically co-administered with β-lactam antibiotics to restore treatment effectiveness, but continual evolution and spread of new β-lactamase variants remain a significant challenge to infectious disease management and public health[6][8].

Other names
Beta-lactamaseβ-lactamaseBeta-lactam antibiotic hydrolaseAntibiotic resistance enzyme
02

Mechanism of action

Hydrolysis of the β-lactam ring, rendering the antibiotic molecule inactive[1][2][8] Resistance inhibition by specific inhibitors (e.g., clavulanic acid acts as a "suicide inhibitor" by binding irreversibly to the active site serine of class A enzymes)[3][5][8]

03

Biological functions

Hydrolysis of beta-lactam antibioticsAntibiotic resistanceDeactivation of antibacterial compoundsBacterial cell survival
04

Disease associations

InfectionMultidrug-resistant bacterial infectionNosocomial (hospital-acquired) infections
05

Safety considerations

Rapid emergence of multidrug-resistant pathogensTransmission of resistance genes among bacteria, including via plasmids[4][8]Limited therapeutic options in severe infections due to high-level resistanceRisk of treatment failure with β-lactam antibioticsNeed for combination therapy with β-lactamase inhibitors for efficacy
06

Interacting drugs

Clavulanic acid

7 more in the full profile.

07

Biomarkers

Expression of β-lactamase genes (e.g., TEM, SHV, CTX-M, KPC, NDM, OXA)Enzyme activity assaysPCR detection of β-lactamase genes in clinical isolatesResistance phenotype in laboratory susceptibility testing

Beyond the preview

Go deeper on Beta-lactamase enzyme (bacterial) (β-lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactamase enzyme (bacterial) (β-lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call